Cochlear Stock

Cochlear EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Cochlear (COH.AX) as of Sep 8, 2026 is 83.23. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 36.81 — a change of 126.11% (higher).

EV/FCF

83.23

YoY

126.11%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Cochlear is 2026 83.23 . EV/FCF (Enterprise Value to Free Cash Flow) of Cochlear was 2025 36.81 . It decreases by 126.11% higher compared to the previous year.

The Cochlear EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
54.52 AUD
Jan 1, 2019
62.73 AUD
Jan 1, 2020
-38.33 AUD
Jan 1, 2021
55.01 AUD
Jan 1, 2022
36.42 AUD
Jan 1, 2023
40.99 AUD
Jan 1, 2024
36.81 AUD
Jan 1, 2025
83.23 AUD
The Cochlear EV/FCF history
YEAREV/FCFYoY
83.23+126.11%
36.81-10.19%
40.99+12.53%
36.42-33.79%
55.01-243.52%
-38.33-161.10%
62.73+15.05%
54.52-9.79%
60.44-21.72%
77.22+8.40%
71.24-50.57%
144.13
Access this data via the Eulerpool API

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

EV/FCF (Enterprise Value to Free Cash Flow) of Cochlear is 83.23 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Cochlear changed from 36.81 to 83.23, representing a 126.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Cochlear since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Cochlear with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Cochlear

All Key Metrics — Cochlear